Bharat Biotech to scale up Covaxin production to 1 billion doses a year

Bharat Biotech on Thursday said it is planning to produce additional 200 million doses of Covaxin per annum, taking the total volume of the vaccine to 1 billion dosages.

Bharat Biotech on Thursday said it is planning to produce additional 200 million doses of Covaxin per annum, taking the total volume of the vaccine to 1 billion (100 crore) dosages. Glad to share a very positive development from us 20/5/21 pic.twitter.com/cA3ZZx8pdc The Hyderabad-based firm said it will utilise the Ankleshwar-based production facility of its wholly-owned subsidiary Chiron Behring Vaccines to add another 200 million doses of Covaxin.